Pharma pushes for UK medicine scheme revision
If proposed changes to the UK’s Statutory Scheme for branded…
If proposed changes to the UK’s Statutory Scheme for branded medicines is implemented, there will be “a negative impact on new product launches, despite any initial exemption in the first three years,” says Astellas.